Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $70,999.18 +3.86%
Ethereum $2,158.07 +5.51%
BNB $635.81 +1.76%
Optimism $0.11 -0.32%
Arbitrum $0.10 +3.76%
Solana $91.27 +6.01%
Polygon $0.22 +2.77%
Cosmos $1.78 +1.29%
Avalanche $9.56 +5.71%

Bitcoin $70,999.18 +3.86%
Ethereum $2,158.07 +5.51%
BNB $635.81 +1.76%
Optimism $0.11 -0.32%
Arbitrum $0.10 +3.76%
Solana $91.27 +6.01%
Polygon $0.22 +2.77%
Cosmos $1.78 +1.29%
Avalanche $9.56 +5.71%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B